Zhejiang University School of Medicine Researchers Update Current Study Findings on Personalized Medicine (PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies).

Předmět:	TRIPLE-negative breast cancer IMMUNE checkpoint proteins BREAST cancer research PROGRAMMED cell death 1 receptors CELL communication
Zdroj:	Women's Health Weekly; 12/20/2024, p1479-1479, 1p
Abstrakt:	Researchers from Zhejiang University School of Medicine have published new insights on personalized medicine, specifically focusing on PD-1/PD-L1 immune checkpoint blockade in breast cancer. The study highlights the importance of identifying responders and optimizing immune drug selection for effective treatment. The research also explores strategies to enhance the effectiveness of immune checkpoint blockade in breast cancer, with the goal of developing personalized treatment approaches tailored to individual tumor characteristics. The findings are published in Molecular Cancer and can be accessed for free online. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu